Latest news with #RSI
Business Insider
7 hours ago
- Business
- Business Insider
Fresh AI Euphoria Boosts AMD Stock Momentum
Advanced Micro Devices (AMD) may no longer be categorized as a traditional value investment; however, it remains a compelling high-growth opportunity within the AI sector, with strong return potential over the next year. Moreover, demand for AI products is mushrooming across all industries and geographies as companies seek to leverage AI to enhance their operations. As a supplier of AI-driven technology, AMD is well-positioned to capitalize on the growing demand. Confident Investing Starts Here: As a confident shareholder, I have set a 12-month price target of approximately $175, representing an estimated 30% upside. However, Wall Street analysts are not quite as bullish despite the stock's 19% climb year-to-date. Should a $175 target be achieved, I intend to strategically reduce my position and reallocate capital toward attractively valued equities with longer-term growth prospects. From a macroeconomic standpoint, several supportive factors continue to strengthen the bullish outlook for AMD. AMD's Rapid Return Resurgence Has Begun AMD is now trading above the 50-week moving average, with the 14-week Relative Strength Index (RSI) at 65. This indicates that the stock is being driven by the bulls again, and it warrants more cautious buying behavior despite a strong return horizon ahead. Investors who are ahead of the game would have bought this stock earlier in the year. Bullish sentiment for AMD stock is understandable. AMD's forward non-GAAP earnings per share (EPS) growth rate is nearly 30%, compared to just 10% for the sector. Also, the trailing 12-month non-GAAP price-to-earnings (P/E) ratio is 37, compared to 23 for the industry. That indicates a stark difference in growth and a very fair valuation compared to the broader industry. This robust growth is primarily fueled by accelerating demand in the artificial intelligence sector, where AMD plays a key role through its involvement in data center infrastructure, particularly with its graphics and central processing units. Management has identified 2026 as a pivotal year for profit realization, following years of strong AI-related revenue expansion. While much of this anticipated growth may now be reflected in the stock's valuation, shares do not appear overvalued, making AMD an attractive candidate for a long-term buy-and-hold strategy with the potential for sustained AI-driven returns. Subtle and Stark Macro Factors Influence AMD's Returns A key near-term catalyst for AMD's continued growth is the potential for interest rate cuts by the Federal Reserve. However, I recognize that an overly aggressive easing cycle could contribute to broader market overvaluation in 2026. Should a significant bull market materialize next year—as I believe is likely—I plan to actively manage my exposure by trimming positions. I may also consider entirely exiting my AMD holdings if the stock appears to have fully priced in several years of anticipated growth. Furthermore, China remains a significant risk. While I'm confident that U.S. diplomacy will prevail over escalations in trade tensions or hot wars evolving, any conflict in Taiwan could disrupt AMD's return horizon (and that of every tech stock) for some time. That's why a cash position to protect from geopolitically induced volatility is so important right now. As TipRanks data shows, AMD's cash position is robust with ~$3 billion in operating cash flo w and ~$2 billion in free cash. However, management has also been making the business more resilient, and Taiwan Semiconductor Manufacturing Company (TSM) is diversifying aggressively into the U.S. to mitigate the risk of being threatened by China. That significantly enhances AMD's supply chain security. Hopefully, China will play a diplomatic role. We have AMD's diversification into the EU to look forward to in the near term, as well as burgeoning opportunities in the Middle East with a new $10 billion arrangement with Saudi Arabia's HUMAIN. Looking longer-term, the Global South appears to be a promising growth climate, with India likely taking center stage. Is AMD a Buy, Hold, or Sell? On Wall Street, AMD stock has a consensus Moderate Buy rating based on 24 Buys, 10 Holds, and zero Sell ratings. AMD's average stock price target is $132.17, indicating an 8% downside potential over the next 12 months. Given the macroeconomic factors and the strong demand for AI, I don't think this is the end of AMD's near-term, elite return horizon. The company has also been buying back stock aggressively, with $2.24 billion worth repurchased in the last 12 months; this significantly improves shareholder value and shows management's conscientiousness. At the same time, $2.44 billion in total debt was issued over the same period, suggesting that management is likely trying to boost short-term sentiment to improve stock returns. That's a clever strategy, if you ask me. AMD Stock Still Has Room to Run When a stock transitions from being undervalued to fairly valued, the instinct may be to exit the position. However, as Charlie Munger—one of the most respected investors of our time—has noted, even modest overvaluation is not necessarily a reason to sell shares of an exceptional company. Long-term success often comes from weathering volatility while remaining focused on the broader upward trajectory. This perspective applies well to AMD. The AI boom continues to gain momentum, and AMD remains a central player in this transformative shift. A 12-month price target of $175 appears not only reasonable but also aligned with what could be considered fair value based on the company's medium-term growth outlook.
Yahoo
14 hours ago
- Business
- Yahoo
Centene (CNC) Loses 5.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Centene (CNC) has been beaten down lately with too much selling pressure. While the stock has lost 5.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier. We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30. Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal. So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound. However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision. The heavy selling of CNC shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 28.12. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand. The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for CNC has increased 0.1%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term. Moreover, CNC currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> . Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Centene Corporation (CNC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
a day ago
- Health
- Medscape
Rapid Sequence Intubation Boosts First-Pass Success
TOPLINE: In a US study of patients without cardiac arrest who required prehospital intubation, rapid sequence intubation (RSI), involving the use of a sedative and paralytic, was associated with increased odds of first-pass success compared with intubation without medication. METHODOLOGY: Researchers performed a retrospective observational analysis using the 2022 Emergency Services Organization Data Collaborative dataset containing records from emergency medical services (EMS) agencies in the US. The analysis included 12,713 patients (median age, 60 years; 58.4% men; 24.2% traumatic cases) who underwent at least one intubation attempt during a 911 response. Patients in cardiac arrest were excluded. The researchers categorized drug-assisted airway management approaches on the basis of medications administered before the initial endotracheal intubation attempt: RSI (including both a sedative and a paralytic; 51.2%), sedative-only intubation (17.9%), paralytic-only intubation (1.3%), and no-medication intubation (29.6%). The primary outcome was first-pass intubation success. TAKEAWAY: The overall first-pass success rate was 75.1%. The adjusted odds of achieving first-pass success were higher with RSI (adjusted odds ratio [aOR], 2.23; 95% CI, 2.00-2.50) and paralytic-only intubation (aOR, 2.11; 95% CI, 1.38-3.24) than with no-medication intubation. RSI showed increased odds of first-pass success compared with sedation-only intubation (aOR, 2.14; 95% CI, 1.88-2.43). Sedation-only intubation showed success rates similar to those of no-medication intubation. IN PRACTICE: "In this analysis of a large national EMS dataset of noncardiac arrest patients undergoing endotracheal intubation, rapid sequence intubation was associated with twofold higher odds of first-pass success compared with sedation-only or no-medication approaches," the authors wrote. SOURCE: The study was led by Jeffrey L. Jarvis, MD, MS, EMT-P, Burnett College of Medicine, Texas Christian University, Fort Worth, Texas. It was published online on June 04, 2025, in the Annals of Emergency Medicine. LIMITATIONS: The study focused solely on the association between drug combination and first-pass success, without evaluating causation, procedure indication appropriateness, adverse events, or clinical outcomes. EMS treatment protocols were not uniform across agencies, and the dataset lacked information on clinician experience with intubation. Variability in EMS protocols and clinician experience, potential data entry or documentation errors (including reliance on self-reported data), and a small sample size for paralytic-only intubations were additional limitations. DISCLOSURES: Funding information was not provided for the study. One author reported serving as an unpaid board member for the National Emergency Medical Service Quality Alliance, the National Association of Emergency Medical Technicians, and the Prehospital Guidelines Consortium, unrelated to this study. He also reported receiving unrestricted honoraria for speaking on various topics at EMS-related conferences. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Time of India
a day ago
- Business
- Time of India
Adani Power shares rally 14% this week amid high trade volumes
The shares of Adani Power have shown an impressive rally, surging 13.8% this week to a high of Rs 605 on the BSE today. This surge is driven by high trading volumes in the stock. Today alone, the stock climbed 4.7% on the BSE in intraday trade. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Contribute ToGau Seva At Hare Krishna Mandir Hare krishna Mandir Donate Now Undo As of 10:50 a.m., the stock's total traded quantity (TTQ) stood at 6.96 lakh shares, with a total turnover of Rs 41.44 crore. The company's total market capitalisation stood at Rs 2.33 lakh crore at that time. On the daily chart, Adani Power has formed impressive long green candles for each day of the week so far. Live Events Technically, shares of Adani Power are trading well above their significant daily exponential moving averages (DEMAs). According to Trendlyne data, the stock's 5-day EMA is currently at 558.3, while the 10-day EMA is at 555.7. The 20-day EMA stands at 555.0, and the 50-day EMA is at 548.3. In terms of longer-term moving averages, the 100-day EMA is placed at 543.3, and the 200-day EMA at 548.6. On the RSI, the stock is oscillating near the 59 mark. An RSI below 30 is considered oversold, while an RSI above 70 is considered overbought. Adani Power share price history Over the past year, shares of Adani Power have declined by 15.64%. However, they have shown a strong recovery in the shorter term, gaining 14.50% year-to-date (YTD). In the last six months, the stock is up 19.03%, while the three-month gain stands at 16.12%. Over the past month, the stock has risen by 9.14%. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Economic Times
a day ago
- Business
- Economic Times
UBS initiates 'Buy' call on PNB Housing Finance, sees 17% upside on strong AUM growth and loan book shift
UBS has initiated coverage on PNB Housing Finance with a 'Buy' rating and a target price of Rs 1,300, implying a 17% upside from the previous day's closing price of Rs 1,110. ADVERTISEMENT The brokerage expects a mid-teen AUM compound annual growth rate (CAGR), driven by product diversification and deeper penetration into emerging and affordable housing segments. UBS projects a 16% AUM CAGR over FY25–27, supported by new business verticals. The share of non-prime loans is expected to rise from 25% in FY25 to 40% by FY27. UBS also noted that PNB Housing trades at a discount to peers despite strong loan growth and improving return on equity (RoE). The company's expanding distribution in mid-market segments is seen as another positive that could support incremental loan growth. The brokerage identified three key drivers of future growth. First, affordable and emerging segments are expected to account for 38% of the loan book by FY27, contributing 75% of incremental growth. Second, prime loans, while declining in share, are expected to contribute 25% to loan growth. Third, the company's entry into developer financing is likely to have a limited impact in the near term but could offer meaningful upside from FY28 enable this expansion, PNB Housing plans to increase its branch network from 356 to 500 by FY27. Also Read: Street Favourite! 10 Nifty micro-cap stocks analysts expect to rally up to 60% ADVERTISEMENT In Thursday's trade, the stock rose 2.5% to close at Rs 1,110.6. It has gained 30% over the past three months and is up 84% in the last two years. In Q4 FY25, the company's net interest income rose 19.2% year-on-year, while net profit grew 28% to Rs 567.1 crore. ADVERTISEMENT Asset quality also improved sequentially. Gross NPA declined to 1.08% from 1.19% in the previous quarter, while net NPA improved to 0.69% from 0.8%.On the technical front, the stock's Relative Strength Index (RSI) stands at 62.2, nearing overbought territory. It is trading above its 20-day, 50-day, 100-day, and 200-day simple moving averages, indicating strong underlying momentum. ADVERTISEMENT Also Read: HDB Financial Services IPO: Should you subscribe? Here's what brokerages say (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
